View in EDS

Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety.

Saved in:
Bibliographic Details
Title: Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety.
Authors: Mitri EA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia.; National Allergy Centre for Excellence, Parkville, Victoria, Australia., Vogrin S; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia., Peter JG; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.; Division of Allergology and Clinical Immunology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital, Cape Town, South Africa., Li PH; Division of Rheumatology and Clinical Immunology, Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong., Copaescu AM; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, Quebec, Canada., Day C; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.; Division of Allergology and Clinical Immunology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital, Cape Town, South Africa., Goh M; Department of Dermatology, Austin Health, Heidelberg, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia., Belmont AP; Section of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Fernando SL; Department of Clinical Immunology and Allergy, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Trubiano JA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia.; National Allergy Centre for Excellence, Parkville, Victoria, Australia.
Corporate Authors: International Network of Antibiotic Allergy Nations (iNAAN) study group
Source: Allergy [Allergy] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12.
Publication Type: Letter
Journal Info: Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42285888
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mitri+EA%22">Mitri EA</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia.; National Allergy Centre for Excellence, Parkville, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Vogrin+S%22">Vogrin S</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Peter+JG%22">Peter JG</searchLink>; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.; Division of Allergology and Clinical Immunology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Li+PH%22">Li PH</searchLink>; Division of Rheumatology and Clinical Immunology, Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.<br /><searchLink fieldCode="AU" term="%22Copaescu+AM%22">Copaescu AM</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Day+C%22">Day C</searchLink>; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.; Division of Allergology and Clinical Immunology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Goh+M%22">Goh M</searchLink>; Department of Dermatology, Austin Health, Heidelberg, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.<br /><searchLink fieldCode="AU" term="%22Belmont+AP%22">Belmont AP</searchLink>; Section of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Fernando+SL%22">Fernando SL</searchLink>; Department of Clinical Immunology and Allergy, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Trubiano+JA%22">Trubiano JA</searchLink>; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia.; National Allergy Centre for Excellence, Parkville, Victoria, Australia.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22International+Network+of+Antibiotic+Allergy+Nations+%28iNAAN%29+study+group%22">International Network of Antibiotic Allergy Nations (iNAAN) study group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227804028%22">Allergy</searchLink> [Allergy] 2026 Jun 12. <i>Date of Electronic Publication: </i>2026 Jun 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>Denmark <i>NLM ID: </i>7804028 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1398-9995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201054538%22">01054538 </searchLink><i>NLM ISO Abbreviation: </i>Allergy <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42285888
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/all.70411
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mitri EA
      – PersonEntity:
          Name:
            NameFull: Vogrin S
      – PersonEntity:
          Name:
            NameFull: Peter JG
      – PersonEntity:
          Name:
            NameFull: Li PH
      – PersonEntity:
          Name:
            NameFull: Copaescu AM
      – PersonEntity:
          Name:
            NameFull: Day C
      – PersonEntity:
          Name:
            NameFull: Goh M
      – PersonEntity:
          Name:
            NameFull: Belmont AP
      – PersonEntity:
          Name:
            NameFull: Fernando SL
      – PersonEntity:
          Name:
            NameFull: Trubiano JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 06
              Text: 2026 Jun 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1398-9995
          Titles:
            – TitleFull: Allergy
              Type: main
ResultId 1